26-28 October 2014 | Philadelphia, PA, USA
Join us in Philadelphia for the premier conference on vaccines and vaccination. The 8th Vaccine & ISV Congress will feature science and public health topics, from primary vaccine research and vaccine manufacturers, to governmental policy, safety and regulation.
If you work as a researcher in vaccine-related topics, in the vaccine industry, or in vaccine policy making, this is your must-attend event in 2014.
Nancy J. Sullivan, USA
Steven Black, USA
Jose A. Chabalgoity, Uruguay
Manon M.J. Cox, USA
Klaus Frueh, USA
Volker Gerdts, Canada
Sanjay Gurunathan, USA
Stephen L. Hoffman, USA
Robert Huebner, USA
Ken Ishii, Japan
Kathrin U. Jansen, USA
Carl June, USA
Chris Bailey Kellogg, USA
Harold Kleanthous, USA
Mi-Na Kweon, Korea
Christian Mandl, USA
Helen McShane, UK
Paul Offit, USA
Klaus Osterrieder, Germany
Stanley A. Plotkin, USA
Valeria Quattrocchi, Argentina
Nicolas Restifo, USA
Daniel Salmon, USA
Connie Schmaljohn, USA
Raphael Simon, USA
Ray Spier, UK
Connie Trimble, USA
Tonya Villafana, USA
Sho Yamasaki, Japan
Qinjian Zhao, China
Adolfo García-Sastre, Mount Sinai School of Medicine, USA
Ted Ross, Vaccine and Gene Therapy Institute of Florida, USA
Volker Gerdts, Canada
Annie De Groot, EpiVax, Inc., USA
Stephen L. Hoffman, Sanaria Inc., USA
Ken Ishii, National Institute of Biomedical Innovation and Osaka University, Japan
Margaret Liu, ProTherImmune, Sweden
Shan Lu, University of Massachusetts, USA
Polly Roy, London School of Hygiene & Tropical Medicine, UK
Olaf Schneewind, University of Chicago, USA
Matthias Schnell, Thomas Jefferson University, USA
David Weiner, University of Pennsylvania, USA
The Vaccine & ISV Congress has enjoyed an exciting history covering all aspects of vaccines since 2007. Over this time a wealth of knowledge has been presented, including talks from eminent scientists such as Stanley A. Plotkin, Rino Rappuoli, Ab Osterhaus, Walter A. Orenstein, Myron M. Levine, Adel Mahmoud and Gregory A. Poland.
This lunchtime symposium will take place during the 8th Vaccine & ISV Congress on Monday 27th October, 2014 and will describe the challenges and opportunities related to raw materials supply into pandemic Influenza vaccine manufacturing processes. For more information, click here.
"The Vaccine Congress provides high level and new and innovative ideas about the vaccine process."
"This congress covers all aspects related to vaccine development which are beneficial to the new researcher to gain knowledge and new ideas for future vaccine study."